Company Overview and News

4
Eastmain and Partners Announce Fall 2018 Exploration Program at Éléonore South Joint Venture

2018-09-11 globenewswire
TORONTO, Sept. 11, 2018 (GLOBE NEWSWIRE) -- Eastmain Resources Inc. (“Eastmain” or the “Company”- TSX:ER, OTCQX:EANRF) announces the Fall 2018 Exploration Program at the Éléonore South Joint Venture Property (“ESJV”) located in James Bay, Quebec (see Figure 1).
EANRF ER AZMTF G MALRY MALRF GG MIN AZM

4
Eastmain Announces Appointment of Maura Lendon to Board of Directors

2018-07-31 globenewswire
TORONTO, July 31, 2018 (GLOBE NEWSWIRE) -- Eastmain Resources Inc. (“Eastmain” or the “Company”- TSX:ER, OTCQX:EANRF) is pleased to announce the appointment of Maura Lendon to the Board of Directors.
EANRF HBM PPPMF ER HBM PPP P GG

4
Winter Drilling Strengthens Model for Large-Scale Intrusive Hosted Gold System at Éléonore South

2018-07-18 globenewswire
TORONTO, July 18, 2018 (GLOBE NEWSWIRE) -- Eastmain Resources Inc. (“Eastmain” or the “Company”) (TSX:ER) (OTCQX:EARNF) is pleased to announce the receipt of assay results from 32 drill holes totalling 5,449 m completed during the winter drilling campaign at the Éléonore South Joint Venture (ESJV) Property (Eastmain-Goldcorp-Azimut). This phase completes the H2/2017-H1/2018 diamond drilling program of 50 holes for a total of 9,892 m.
EANRF ER AZMTF G MALRY MALRF GG MIN AZM

4
Eastmain Resources Announces Closing of C$5.75M Bought Deal Private Placement

2018-07-05 globenewswire
THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
EANRF ER MALRY MALRF MIN GG

4
Eastmain dépose le rapport technique de l'évaluation économique préliminaire (EEP) et la mise à jour de l'estimation des ressources minérales du gisement Eau Claire

2018-07-04 globenewswire
TORONTO, 04 juill. 2018 (GLOBE NEWSWIRE) -- Eastmain Resources Inc. («Eastmain» ou la «Société») – (TSX : ER, OTCQX : EANRF) annonce que la société a déposé le rapport technique 43-101 intitulé «Technical Report, Updated Mineral Resource Estimate and Preliminary Economic Assessment on the Eau Claire Gold Deposit, Clearwater Property, Québec, Canada», préparé par P&E Mining Consultants Inc. («P&E») tel qu'initialement divulgué le 23 mai 2018, sur le profil de la Société sur SEDAR (www.
EANRF ER GG

4
Eastmain Files Technical Report for Preliminary Economic Assessment and Updated Mineral Resource Estimate at the Eau Claire Project

2018-07-04 globenewswire
TORONTO, July 04, 2018 (GLOBE NEWSWIRE) -- Eastmain Resources Inc. (“Eastmain” or the “Company”) (TSX:ER) (OTCQX:EANRF) announces the Company has filed the 43-101 Technical Report titled, “Technical Report, Updated Mineral Resource Estimate and Preliminary Economic Assessment on the Eau Claire Gold Deposit, Clearwater Property, Quebec, Canada”, prepared by P&E Mining Consultants Inc. (“P&E”) as initially disclosed May 23rd, 2018 on the Company’s profile on SEDAR (www.
EANRF ER MALRY MALRF MIN GG

9
Eastmain Resources Announces C$5 Million Bought Deal Private Placement

2018-06-14 globenewswire
THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
EANRF ER MALRY MALRF MIN GG

9
UPDATE: Eastmain Announces Robust Preliminary Economic Assessment and Updated Mineral Resource Estimate at the Eau Claire Project

2018-05-23 globenewswire
TORONTO, May 23, 2018 (GLOBE NEWSWIRE) -- Eastmain Resources Inc. (“Eastmain” or the “Company”) (TSX:ER) (OTCQX:EANRF) is reissuing this morning’s press release due to minor corrections of certain footnotes as requested by one of the Qualified Persons. These changes are non-material and do not impact any quantitative figures previously released.
EANRF ER MALRY MALRF MIN GG

9
Eastmain Announces Robust Preliminary Economic Assessment and Updated Resource Estimate at the Eau Claire Project

2018-05-23 globenewswire
TORONTO, May 23, 2018 (GLOBE NEWSWIRE) -- Eastmain Resources Inc. (“Eastmain” or the “Company”) (TSX:ER) (OTCQX:EANRF) is pleased to announce positive and robust results of a Preliminary Economic Assessment (“PEA”) on its 100%-owned Eau Claire Gold Project (“Eau Claire” or “Project”) located in James Bay, Québec. All figures are in Canadian dollars, unless stated.
EANRF ER MALRY MALRF MIN GG

9
Eastmain Announces Conference Call to Discuss Eau Claire PEA Expected May 23, 2018

2018-05-18 globenewswire
TORONTO, May 18, 2018 (GLOBE NEWSWIRE) -- Eastmain Resources Inc. (“Eastmain” or the “Company”) (TSX:ER) (OTCQX:EANRF) expects to announce results of its Preliminary Economic Assessment (“PEA”) on its 100%-owned Eau Claire project located in James Bay, Quebec on Wednesday, May 23, 2018 before market open.
EANRF ER MALRY MALRF MIN GG

5
Eastmain Reports Voting Results from Annual General Meeting

2018-04-27 globenewswire
TORONTO, April 27, 2018 (GLOBE NEWSWIRE) -- Eastmain Resources Inc. (“Eastmain” or the “Company”) (TSX:ER) (OTCQX:EANRF) has released the voting results from its annual general meeting held Thursday April 26, 2018, in Toronto, Ontario, in accordance with Toronto Stock Exchange requirements.
EANRF ER GG

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

Silicon Investor Message Boards

This table lists all message boards related to TSX:ER / Eastmain Res J on message board site Silicon Investor.

Politics for Pros- moderated Politics for Pros- moderated Politics for Pros- moderated A Real American President: Donald Trump A Real American President: Donald Trump A Real American President: Donald Trump
View from the Center and Left View from the Center and Left View from the Center and Left Qualcomm Moderated Thread - please read rules before posting Qualcomm Moderated Thread - please read rules before posting Qualcomm Moderated Thread - please read rules before posting
Buy and Sell Signals, and Other Market Perspectives Buy and Sell Signals, and Other Market Perspectives Buy and Sell Signals, and Other Market Perspectives OLED Universal Display Corp OLED Universal Display Corp OLED Universal Display Corp
2026 TeoTwawKi ... 2032 Darkest Interregnum 2026 TeoTwawKi ... 2032 Darkest Interregnum 2026 TeoTwawKi ... 2032 Darkest Interregnum Liberalism: Do You Agree Weu0027ve Had Enough of It? Liberalism: Do You Agree Weu0027ve Had Enough of It? Liberalism: Do You Agree Weu0027ve Had Enough of It?
Formerly About Advanced Micro Devices Formerly About Advanced Micro Devices Formerly About Advanced Micro Devices Infinera Infinera Infinera